wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35675340-CECC169F-3A79-42E2-A2C2-59B0ECA2DDB2
Q35675340-CECC169F-3A79-42E2-A2C2-59B0ECA2DDB2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35675340-CECC169F-3A79-42E2-A2C2-59B0ECA2DDB2
Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma.
P2860
Q35675340-CECC169F-3A79-42E2-A2C2-59B0ECA2DDB2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35675340-CECC169F-3A79-42E2-A2C2-59B0ECA2DDB2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ed28f3c2911f866002b09172ec61eb291df7c804
P2860
A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumors